Breast (Jun 2024)

French college of gynecologists and obstetricians (CNGOF) recommendations for clinical practice: Place of breast self-examination in screening strategies

  • Vincent Lavoue,
  • Amélia Favier,
  • Sophie FRANCK,
  • Gérard Boutet,
  • Anne-Sophie Azuar,
  • Susie Brousse,
  • François Golfier,
  • Catherine Uzan,
  • Charlotte Vaysse,
  • Sébastien Molière,
  • Martine Boisserie-Lacroix,
  • Edith Kermarrec,
  • Jean-Yves Seror,
  • Yann Delpech,
  • Élisabeth Luporsi,
  • Christine M. Maugard,
  • Nicolas Taris,
  • Nathalie Chabbert-Buffet,
  • Jonathan Sabah,
  • Khalid Alghamdi,
  • Xavier Fritel,
  • Carole Mathelin

Journal volume & issue
Vol. 75
p. 103619

Abstract

Read online

Breast cancer is the most common female cancer in the world. Numerous studies have shown that the risk of metastatic disease increases with tumor volume. In this context, it is useful to assess whether the regular practice of formal breast self-examination (BSE) as opposed to breast awareness has an impact on the number of cancers diagnosed, their stage, the treatments used and mortality. Design: The Commission of Senology (CS) of the Collège National de Gynécologie et Obstétrique Français (CNGOF) respected and followed the Grading of Recommendations Assessment, Development and Evaluation method to assess the quality of the evidence on which the recommendations were based. Methods: The CS studied 16 questions individualizing four groups of women (general population, women aged over 75, high-risk women, and women previously treated for breast cancer). For each situation, it was determined whether the practice of BSE versus abstention from this examination led to detection of more breast cancers and/or recurrences and/or reduced treatment and/or increased survival. Results: BSE should not be recommended for women in the general population, who otherwise benefit from clinical breast examination by practitioners from the age of 25, and from organized screening from 50 to 74 (strong recommendation). In the absence of data on the benefits of BSE in patients aged over 75, for those at high risk and those previously treated for breast cancer, the CS was unable to issue recommendations. Thus, if women in these categories wish to undergo BSE, information on the benefits and risks observed in the general population must be given, notably that BSE is associated with a higher number of referrals, biopsies, and a reduced quality of life.

Keywords